相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma
MacLean P. Nasrallah et al.
ACADEMIC PATHOLOGY (2019)
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
Zev A. Binder et al.
CANCER CELL (2018)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
OS11.5 ACT IV: An international, double-blind, phase 3 trial of rindopepimut in newly diagnosed, EGFRvIII-expressing glioblastoma
M. Weller et al.
NEURO-ONCOLOGY (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Ex vivo multiplex profiling of protein tyrosine kinase activities in early stages of human lung adenocarcinoma
Stephan Arni et al.
Oncotarget (2017)
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
Martin van den Bent et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Clustered localization of EGFRvIII in glioblastoma cells as detected by high precision localization microscopy
Philip S. Boyd et al.
NANOSCALE (2016)
Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines
Matthias Riedel et al.
ONCOTARGET (2016)
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
Uros Smrdel et al.
RADIOLOGY AND ONCOLOGY (2016)
Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide
Jose L. McFaline-Figueroa et al.
CANCER RESEARCH (2015)
EGFR Amplified and Overexpressing Glioblastomas and Association With Better Response to Adjuvant Metronomic Temozolomide
Manuela Cominelli et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas
Martin J. van den Bent et al.
NEURO-ONCOLOGY (2015)
Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest
Malte Kriegs et al.
RADIOTHERAPY AND ONCOLOGY (2015)
EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
Nina Struve et al.
ONCOTARGET (2015)
EGFR Amplified and Overexpressing Glioblastomas and Association With Better Response to Adjuvant Metronomic Temozolomide
Manuela Cominelli et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers
Claire Faulkner et al.
BRITISH JOURNAL OF NEUROSURGERY (2015)
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy
Michael Weller et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma
Qifan Zheng et al.
NEURO-ONCOLOGY (2014)
EGFR Phosphorylates Tumor-Derived EGFRvIll Driving STAT3/5 and Progression in Glioblastoma
Qi-Wen Fan et al.
CANCER CELL (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage
Motokazu Ito et al.
PLOS ONE (2013)
Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
Michal Bienkowski et al.
PLOS ONE (2013)
Epidermal g o h factor receptor mutation status and Rad5l determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation
Phyllis Rachelle Wachsberger et al.
FRONTIERS IN ONCOLOGY (2013)
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Gordon Li et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
Joerg Felsberg et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Oncogenic EGFR Signaling Activates an mTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka et al.
CANCER DISCOVERY (2011)
Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited
Nicola Montano et al.
NEOPLASIA (2011)
Processing of O-6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles
Steve Quiros et al.
CELL CYCLE (2010)
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
David M. Peereboom et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
J. Dunn et al.
BRITISH JOURNAL OF CANCER (2009)
EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
Bipasha Mukherjee et al.
CANCER RESEARCH (2009)
The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation
Jana Portnow et al.
CLINICAL CANCER RESEARCH (2009)
MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
Stephen Yip et al.
CLINICAL CANCER RESEARCH (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA
Nina Mojas et al.
GENES & DEVELOPMENT (2007)
Clinical significance of EGFR amplification and the aberrant EGFRVIII transcript in conventionally treated astrocytic gliomas
L Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Measurement of DNA mismatch repair activity in live cells
XF Lei et al.
NUCLEIC ACIDS RESEARCH (2004)
Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms
I Gazzoli et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV
SJ Scherer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
